Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bactrom S.A. is an Argentine pharmaceutical company primarily focused on the production and distribution of essential medicines, with a strong emphasis on anti-infective therapies. The company is best known for its namesake product, Bactrom, which is a widely used brand of the antibiotic combination sulfamethoxazole and trimethoprim. Beyond its core antibiotic portfolio, the company manufactures a range of generic and branded pharmaceutical products across various therapeutic areas, including analgesics and anti-inflammatories. Bactrom serves the regional healthcare market by providing affordable access to critical treatments for common bacterial infections and other primary care conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bactrom.